The mek1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma

Mikhail S. Chesnokov, Imran Khan, Yeonjung Park, Jessica Ezell, Geeta Mehta, Abdelrahman Yousif, Linda J. Hong, Ronald J. Buckanovich, Akimasa Takahashi, Ilana Chefetz

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'The mek1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences